相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clear Cell Adenocarcinoma With a Component of Poorly Differentiated Histology: A Poor Prognostic Subgroup of Ovarian Clear Cell Adenocarcinoma
Sohei Yamamoto et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient
Sohei Yamamoto et al.
MODERN PATHOLOGY (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Cumulative alterations of p27Kip1-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma
Sohei Yamamoto et al.
HISTOPATHOLOGY (2010)
An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Reduces Tumor Burden and Metastasis in a Preclinical Model of Ovarian Cancer Metastasis
Marion Zillhardt et al.
NEOPLASIA (2010)
Immunopathogenesis of Pelvic Endometriosis: Role of Hepatocyte Growth Factor, Macrophages and Ovarian Steroids
Khaleque Newaz Khan et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2008)
Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)
Hiroaki Nitta et al.
DIAGNOSTIC PATHOLOGY (2008)
Expression and Mutational Analysis of MET in Human Solid Cancers
Patrick C. Ma et al.
GENES CHROMOSOMES & CANCER (2008)
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
John K. Chan et al.
GYNECOLOGIC ONCOLOGY (2008)
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts
H. Toni Jun et al.
CLINICAL CANCER RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
Kenjiro Sawada et al.
CANCER RESEARCH (2007)
Ovarian clear cell adenocarcinoma: a continuing enigma
David S. P. Tan et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Molecular genetic evidence that endometriosis is a precursor of ovarian cancer
Amanda H. Prowse et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary
Mika Mizuno et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Targeting the c-Met signaling pathway in cancer
Benedetta Peruzzi et al.
CLINICAL CANCER RESEARCH (2006)
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
M. Takano et al.
BRITISH JOURNAL OF CANCER (2006)
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
GA Smolen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis
XJ Zhao et al.
CANCER RESEARCH (2005)
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer
F Cappuzzo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Functional expression and mutations of c-met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer
PC Ma et al.
CANCER RESEARCH (2005)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics
K Matsumoto et al.
CANCER SCIENCE (2003)
c-Met: Structure, functions and potential for therapeutic inhibition
PC Ma et al.
CANCER AND METASTASIS REVIEWS (2003)
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer:: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
G Pauletti et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
